These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8674763)

  • 1. Effect of pertussis toxin and PGE2 on the functioning of the IL-2 promoter in interleukin-1 treated EL4.NOB-1 thymoma cells.
    McCarthy LM; O'Neill LA
    Biochem Soc Trans; 1996 Feb; 24(1):82S. PubMed ID: 8674763
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of pertussis toxin and its binding subunit on IL-1 signalling in T cells.
    McCarthy LM; O'Neill LA
    Biochem Soc Trans; 1995 Feb; 23(1):112S. PubMed ID: 7758673
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation into the role of protein kinase C in IL1 and PMA signalling in EL4.NOB-1 thymoma cells.
    Mahon TM; O'Neill LA
    Biochem Soc Trans; 1996 Feb; 24(1):81S. PubMed ID: 8674762
    [No Abstract]   [Full Text] [Related]  

  • 4. Modification of biological responses to interleukin-1 by agents that perturb signal transduction pathways.
    Rollins P; Witham S; Ray K; Thompson N; Sadler H; Smithers N; Grenfell S; Solari R
    Cytokine; 1991 Jan; 3(1):42-53. PubMed ID: 1715770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 induces a pertussis toxin-sensitive increase in diacylglycerol accumulation in mouse thymoma cells.
    Dobson PR; Plested CP; Jones DR; Barks T; Brown BL
    J Mol Endocrinol; 1989 May; 2(3):R5-7. PubMed ID: 2787652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways.
    Paliogianni F; Kincaid RL; Boumpas DT
    J Exp Med; 1993 Nov; 178(5):1813-7. PubMed ID: 7693857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 stimulates a diverging signaling pathway in EL4 6.1 thymoma cells. IL-2 release, but not IL-2 receptor expression, is sensitive to pertussis toxin.
    Zumbihl R; Dornand J; Fischer T; Cabane S; Rappuoli R; Bouaboula M; Casellas P; Rouot B
    J Immunol; 1995 Jul; 155(1):181-9. PubMed ID: 7602094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 signalling: synergy with Rac1 and Pi3 kinase.
    O'Neill LA; Matthews JS; Pålsson E; Jeffries C; Brennan P; Cantrell DA
    Biochem Soc Trans; 1997 Nov; 25(4):S578. PubMed ID: 9450006
    [No Abstract]   [Full Text] [Related]  

  • 9. A role for protein kinase C activity in interleukin-1 (IL-1) induction of IL-2 gene expression but not in IL-1 signal transduction.
    Macchia G; Baldari CT; Massone A; Telford JL
    Mol Cell Biol; 1990 Jun; 10(6):2731-7. PubMed ID: 1692959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation.
    Novak TJ; Chen D; Rothenberg EV
    Mol Cell Biol; 1990 Dec; 10(12):6325-34. PubMed ID: 2174106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding subunit of pertussis toxin inhibits IL-1 induction of IL-2 and prostaglandin production.
    O'Neill LA; Ikebe T; Sarsfield SJ; Saklatvala J
    J Immunol; 1992 Jan; 148(2):474-9. PubMed ID: 1309558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of cytokine-induced modulation of beta-adrenoceptor responsiveness in airway smooth muscle.
    Hakonarson H; Herrick DJ; Serrano PG; Grunstein MM
    J Clin Invest; 1996 Jun; 97(11):2593-600. PubMed ID: 8647953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1.
    Matthews JS; O'Neill LA
    Cytokine; 1999 Sep; 11(9):643-55. PubMed ID: 10479400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergizes with interleukin 1alpha in EL4 thymoma cells.
    Mahon TM; Matthews JS; O'Neill LA
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):39-45. PubMed ID: 9224627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the mouse IL-2 gene by okadaic acid: synergy with interleukin-1.
    Falk W; Stricker K; Praast G; Tsukitani Y; Krammer PH; Stoeck M
    Lymphokine Cytokine Res; 1994 Jun; 13(3):167-74. PubMed ID: 7948425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPA induction of EL4 resistance to macrophage-released TNF: role of ADP-ribosylation in tumoricidal activities of TNF and other factors.
    Fishman M; Essani N; Costlow M
    Cell Immunol; 1990 Apr; 127(1):78-91. PubMed ID: 2138520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 activates transcription factor NF kappa B in glial cells.
    Moynagh PN; Williams DC; O'Neill LA
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):343-7. PubMed ID: 8373349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells.
    Fehmann HC; Habener JF
    Endocrinology; 1992 May; 130(5):2890-6. PubMed ID: 1374016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid inhibits lipogenic gene expression in 3T3-L1 adipocytes through a prostanoid pathway.
    Mater MK; Pan D; Bergen WG; Jump DB
    J Lipid Res; 1998 Jul; 39(7):1327-34. PubMed ID: 9684735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of the protein kinase C inhibitor staurosporine on the interleukin-1 and phorbol ester activation pathways in the EL4-6.1 thymoma cell line.
    Dornand J; Bouaboula M; d'Angeac AD; Favero J; Shire D; Casellas P
    J Cell Physiol; 1992 Apr; 151(1):71-80. PubMed ID: 1560050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.